Amicus Therapeutics Email Format
Biotechnology ResearchNew Jersey, United States501-1000 Employees
Amicus Therapeutics is now part of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. For more information on BioMarin, please visit https://www.biomarin.com/ and follow @BioMarin Pharmaceutical Inc. on LinkedIn for updates.